RCKT
Rocket Pharmaceuticals Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$3.070
Kõrge
$3.070
Madal
$3.070
Maht
3.11M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
Canaccord Genuity Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $11
Canaccord Genuity analyst Whitney Ijem maintains Rocket Pharmaceuticals with a Buy and lowers the price target from $34 to $11.
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety concerns.
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
Rocket Pharmaceuticals faces trial delays, multiple downgrades, and reduced success expectations following RP-A501 safety concerns.
B of A Securities Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $9
B of A Securities analyst Greg Harrison maintains Rocket Pharmaceuticals with a Buy and lowers the price target from $32 to $9.
BMO Capital Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $8
BMO Capital analyst Kostas Biliouris maintains Rocket Pharmaceuticals with a Outperform and lowers the price target from $30 to $8.
Scotiabank Maintains Sector Outperform on Rocket Pharmaceuticals, Lowers Price Target to $19
Scotiabank analyst Greg Harrison maintains Rocket Pharmaceuticals with a Sector Outperform and lowers the price target from $51 to $19.
Leerink Partners Downgrades Rocket Pharmaceuticals to Market Perform, Lowers Price Target to $8
Leerink Partners analyst Mani Foroohar downgrades Rocket Pharmaceuticals from Outperform to Market Perform and lowers the price target from $37 to $8.
Seotud aktsiad
VLY
Valley National Bancorp
BGB
Blackstone Strategic Credit 2027 Term Fund Common Shares of Beneficial Interest
BTT
BlackRock Municipal 2030 Target Term Trust
BOKF
BOK Financial Corporation
BWAY
BrainsWay Ltd. American Depositary Shares
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.